EDUCATION/POST GRADUATE TRAINING 2002-2008 MD, Tokyo Medical University, 2020 PhD in Cardiovascular medicine, Toho University Residency: 2008-2010 Resident in Internal Medicine, Tokyo Medical University Ibaraki Medical Center , Ibaraki, Japan. Fellowship: 2010-2012 Fellow in Comprehensive Internal Medicine, Tokyo Metropolitan Tama Medical Center, Tokyo, Japan. 2012-2014 Fellow in Cardiology, Toho University Ohashi Medical Center, Tokyo, Japan. 2014 – 2019 Department of Cardiology, National Center for Global Health and Medicine,Tokyo, Japan. 2019 - present Department of Cardiovascular Medicine, Toho University Ohashi Medical Center, Tokyo, Japan. Publication – Journals 1. Awaya T et al., What Should We Do after the COVID-19 Vaccination? Vaccine-Associated Diseases and Precautionary Measures against Adverse Reactions. Vaccines (Basel). 2022 May 28;10(6):866. 2. Myocarditis after COVID-19 mRNA vaccines T Koizumi, T Awaya et al. QJM. 2021 Sep 21:hcab244. 3. Performance of 99mTc-aprotinin scintigraphy for diagnosing light chain (AL) cardiac amyloidosis confirmed by endomyocardial biopsy. Awaya T et al. J Nucl Cardiol. (2020) 27:1145-1153. 4. Two cases of giant cell myocarditis with ocular symptoms. S Kitano, T Awaya et al. Can J Cardiol. 2023 Mar 23:S0828-282X(23)00269-6. 5. Effect of Membranous Septal Length on the Risk of Atrioventricular Block in Patients Undergoing Transcatheter Aortic Valve Implantation. Kozai Y, Awaya T et al. Circ Rep. 2021 Dec 10;4(1):68-69.